Encompass Study
Are You Eligible?The objective of the Encompass clinical trial is to evaluate the safety and performance of the F2 Filter and Delivery System in preventing embolic material from traveling to the brain during transcatheter aortic valve replacement (TAVR)
Research Objectives
Status
Recruitment
Total participants required
Study location
Study type
Patient group
About this clinical trial
The Encompass clinical trial is a groundbreaking study investigating the potential of the F2 Filter and Delivery System to revolutionize transcatheter aortic valve replacement (TAVR) by safeguarding patients against stroke-causing debris. This innovative device aims to capture and eliminate embolic material, harmful particles that can dislodge during TAVR and travel to the brain, potentially leading to stroke.
By participating in this trial, individuals undergoing TAVR have the opportunity to receive cutting-edge treatment while contributing to the advancement of medical care. The trial’s findings will determine whether the F2 Filter and Delivery System can enhance the safety and effectiveness of TAVR, offering patients a safer and more effective alternative to traditional open-heart surgery.
Lead investigator
- Dr Karl Poon
Experienced investigator
- Dr Alexander Incani
Clinical trial coordinators
- Linda Pearce
- Sarah Harriman
Technical title
A Prospective, Single-arm, Multicenter Feasibility Trial to Evaluate the Safety and Performance of the F2 Filter and Delivery System Used for Embolic Protection during Transcatheter Aortic Valve Replacement
Contact for more information
If you would like more information about this clinical trial, please complete the contact form below.